Cambrooke Therapeutics announced the launch of Glytactin RESTORE Powder and Glytactin RESTORE Lite Powder, new medical food hydration beverages for the dietary management of phenylketonuria (PKU).
Cambrooke Therapeutics announced the launch of KetoVie Peptide, the first ketogenic hydrolyzed whey-based (peptides) formula for patients on a ketogenic diet with milk protein sensitivities and/or impaired digestive function.
Evidence is lacking that hydrolyzed infant formulas protect children from autoimmune disorders, according to a review published online March 8 in The BMJ
Alcresta has received de novo approval from the FDA to market Relizorb (immobilized lipase), a first-of-its kind digestive enzyme cartridge that breaks down fats in enteral tube feeding formula to mimic normal pancreatic function.
The Food and Drug Administration (FDA) has announced a final rule on the required nutrients for infant formula, along with minimum and maximum levels of the newly required mineral effective immediately.
Medolac Laboratories and the Mothers Milk Cooperative announced the launch of Co-op Donor Milk, the first direct-to-consumer human donor milk that can be stored at room temperature.
One in every ten samples of breast milk bought over the Internet contained significant amounts of cow's milk, results from a new study showed.
In an updated position paper, the Academy of Nutrition and Dietetics stated that breastfeeding provides the best nutrition for infants and very young children.
Prolacta Bioscience announced the launch of Prolact RTF, the first ready-to-feed (RTF) human milk-derived premature infant formula.
Use of high-protein enteral nutrition enriched with immune-modulating nutrients (IMHP) does not reduce the incidence of infectious complications among mechanically ventilated, critically ill patients.
For patients with well-controlled type 2 diabetes, consumption of whey protein pre-load before a high-glycemic index breakfast correlates with a reduction in glucose levels, higher insulin responses, and higher glucagon-like peptide-1 (GLP-1) levels.
Use of supplementation with in-hospital formula shortens the duration of breastfeeding among first-time mothers who intend to breastfeed exclusively
Women who indicated interest in breastfeeding at the first prenatal visit were significantly more likely to have the discussion.
Human milk purchased over the Internet exhibits high overall bacterial growth and is often contaminated with pathogenic bacteria.
Almost all new mothers experience breastfeeding concerns in the early postpartum period, and these are associated with stopping breastfeeding.
For critically ill patients with relative contraindications to early enteral nutrition, the provision of early parenteral nutrition is not associated with reductions in day-60 mortality.
There is some evidence that supplementation with a prebiotic may prevent eczema in formula-fed infants, but more research is needed before routine use of prebiotics can be recommended.
About 40% of mothers introduce solid food to their infants before the recommended four months of age, with an even higher prevalence for formula-fed infants.
For adults requiring invasive mechanical ventilation, enteral nutrition management without residual gastric volume monitoring is not inferior to a similar protocol which includes monitoring for protection against ventilator-associated pneumonia (VAP).
For infants, supplementation of formula with long-chain polyunsaturated fatty acids (LCPUFAs) correlates with improved visual acuity in the first year of life.
Abbott announced the launch of Ensure Complete shakes, an expansion of their Ensure product line of oral nutrition supplements for adults.
Patients with invasive malignancies who take L-carnitine supplements do not experience a reduction in fatigue, pain, or depression.
Bottle-fed infants have a significantly increased risk of developing pyloric stenosis (PS) in the first few months after birth, compared with infants who are not bottle-fed.